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Simple Summary: Vertical alveolar osteogenesis distraction (VAOD) technique appears to provide
the best results in terms of vertical bone gain. Before its use in humans, most devices are tested
on experimental animals. Currently, there is no consensus on which is the ideal biological animal
model for VAOD studies. In this review, it has been found that the animal model influences the
results. In addition, the most used, easier to handle, and with less complications was the Mongrel dog.
The use of pigs and minipigs, given their difficult handling and poor hygiene, is not recommended.
Abstract: This study is aimed at synthesizing all available evidence on vertical alveolar osteogenesis
distraction (VAOD) in animal trials to determine whether the animal model used and its handling
influence or not, and find which is the most appropriate animal model for this specific technique.
This systematic review has been carried out following the PRISMA statements. Bibliographic sources
have been consulted manually by two reviewers. Risk of bias was assessed using a version of the
Newcastle-Ottawa-Scale (NOS). The selection criteria established by expert researchers were applied
in order to decide which studies should be included in the review. Twenty-six studies met the inclusion
criteria and were included in the review. Twenty-four of them had a high quality (score between
7 and 9), two medium quality (score between 4 and 6), and none low quality (score between 1 and
3). The highest possible score was 9 (using the NOS). Six studies complied with all NOS criteria.
The animal model has been seen to influence the results, leading to failure in some cases. The most
used animal model on VAOD, with fewer complications, was the Mongrel dog. The use of the pig
and minipig is not recommended, due to the difficulties in handling and complications encountered.
Keywords: animal model; animal experimentation; distraction osteogenesis; biomaterials; alveolar
ridge augmentation; VAOD; systematic review
1. Introduction
In oral implantology, one of the most common challenges is the deficiency of mandibular or
maxillary alveolar bone height or width. The causes of bone loss include pathological processes such
as trauma, periodontal disease, tumor resections, and congenital malformations [1].
Currently, the available techniques that allow the use of long implants without reducing the
vertical size of the crown are: augmentation of the floor of the maxillary sinus, the placement of
pterygoid implants, and dental nerve transposition [2]. To modify the crown-implant length ratio,
other techniques such as guided bone regeneration (GBR), autologous bone grafting, and vertical
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alveolar distraction can be used [3]. All these techniques increase alveolar ridge height and, thereby,
allow the utilization of shorter crowns and large implants.
The biological basis of osteogenic distraction (OD) is called callotasis (etymology: tasis =
elongation), which is the progressive elongation of the callus formed around bony portions created by
the osteotomy. This elongation process is progressive, allowing for the preservation of the bloodstream.
The bone regeneration mechanism is made up of two procedures: histogenesis (elongation of the soft
tissues, like blood vessels, nerves, and mucoperiosteum) and osteogenesis (creation of the callus and
consequently the generation of new bone) [4].
The OD technique involves the following phases: (A) surgery, (B) latency, (C) distraction, and (D)
consolidation. The distraction period includes two different phenomena: the distraction frequency
(which is the amount of distraction activations that are performed per day) and the distraction rate
(which is the daily amount of bone gained between the basal bone and the transport fragment, measured
usually in millimeters) [1].
The vertical alveolar osteogenesis distraction (VAOD) procedure is an effective remedy for soft
tissue and bone formation in boneless areas which hinder the rehabilitation with dental implant [1,3].
On the transport segment and the basal bone, a distraction device is placed after executing an osteotomy
in the alveolar bone. Periosteum blood flow must be maintained so that the transport segment remains
vascularized. Then, the transport segment is submitted to gradual pulling forces to move away from
the basal bone. This procedure activates the mechanism which will promote the bone regeneration and
the maturity of the distraction callus created [3].
Berhard von Langenbeck carried out, in 1869, the first experimental research on long bone
distraction. The fist studies on oral distraction were conducted in 1927 by Rosenthal [4]. In view of the
numerous complications that arose, several authors criticized the procedure. In human membranous
mandibular bone, the first osteogenic distraction was performed by Snyder et al. in 1973 [5].
Nevertheless, Gabriel Abramowitch Ilizarov developed the full technique in the 1950s, performing
numerous experiments in dogs. Thanks to this author, a great advance in the clinical use of the
procedure was achieved. Ilizarov also defined the biological basis of the distraction osteogenesis:
(1) tension-stress principle influence, (2) bone shape and mass influence, and (3) influence of interaction
between mechanical load and blood supply [4].
We can differentiate between two types of distraction gadgets: extraosseous and intraosseous.
Depending on their role, there is also a distinction between distractor-implants and distractors [1].
Finally, distractor devices can be classified into horizontal or vertical according to the direction of the
regenerated new bone segment.
In a systematic review, Esposito et al. [1] did not have sufficient proof about which was the best
procedure. Nevertheless, they informed that VAOD had the best capacity for vertical regeneration
among the existing procedures.
Compared to other tissue augmentation treatments, the distraction technique has several
advantages [6]:
- No donor site morbidity.
- Simplest procedure.
- Graft resorption less chance.
- The quantity gained is more predictable.
- The rate of infection and bone resorption is lower
- Most of complications are minor.
- Possibility of implant placement in the transported fragment.
- The consolidation period is shorter, so the treatment has a shorter duration.
- When the results are not satisfactory, complementary techniques can be used.
However, it also presents a series of possible disadvantages (Supplementary Table S1) [6,7].
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Nonetheless, OD has achieved a certain level of application in maxillofacial and implant surgery
as a technique for alveolar bone augmentation. However, there is still no consensus on which is
the ideal animal biological model for vertical bone distraction assessment. For the experimental
evaluation of alveolar distraction, we need a suitable biological model. This model should offer an
adequate amount of bone for the device to be placed on, and subsequently design distraction devices
for clinical use in humans. Tests for mandibular alveolar distraction have been developed in small
animals, such as rats or rabbits, and in medium and large animals, such as dogs, sheep, minipigs,
goats, and primates. Nonhuman primates could represent the ideal biological model for the VAOD
research. However, its high cost, the ethical concerns, and difficult handling make it almost not feasible.
Currently, the selection of an animal biological model for VAOD is still undefined [8].
This study is aimed at collecting all available evidence on VAOD studies in animals to determine
whether the animal model used and its handling influence or not, and find which is the most appropriate
animal model for VAOD studies.
2. Materials and Methods
This systematic review has been carried out following the PRISMA statements (Supplementary
Table S2). Ethics approval was not required for this review. It was performed in the following health
science data bases: PubMed, Scopus, and Web of Science (WOS) (limiting the search until December
2019). This search was carried out manually during the month of December 2019 by two reviewers.
The selection criteria incorporated permutations of the following terms: “Alveolar vertical
distraction”, “dental implant”, “animal model”, “biological model”, “alveolar ridge”, “vertical alveolar
ridge distraction”, “distraction osteogenesis”, “alveolar ridge augmentation”, “alveolar bone loss”,
“atrophic jaws”.
PICO methodology. Animal models (P = patients), experimental studies (I = intervention),
of different species (C = comparison), used for VAOD (O = result). PICO question: What is the most
appropriate animal model to use in VAOD experimental studies?
Eligibility criteria. The studies have been selected according to the following pattern:
1. Experimental studies of alveolar bone distraction aimed at vertical augmentation.
2. Animals used as biological models.
3. Articles in English.
Quality assessment. We used a version of the Newcastle-Ottawa Scale (NOS) to evaluate the
quality of the studies with a maximum of 9 stars. Within the analysis, the studies were defined as low
quality (1–3), medium quality (4–6), or high quality (7–9). The quality of the studies was assessed in
duplicate and independently by two reviewers (M.G.-G and F.M.).
Analysis and extraction of parameters of interest. The studies were evaluated by analyzing the
following items: number of animals used (patient number), age, weight, distractor details, number of
distractors used, number of distraction segments, location of the distractor (jaw/maxilla and segment
site), distraction succession (phase of latency, phase of activation and phase of consolidation), rate and
frequency of distraction, vertical bone gain obtained at the end of the study, specification of the
quantification method analysis, and description of the complications observed.
Regarding the studies in which complications were observed, they were classified as minor and
major [9]. In addition, the phase in which they were observed was detailed [10].
3. Results
The initial search generated 921 articles. Figure 1 shows the flow chart of the selected articles
submitted to the review process. After the exclusion of duplicates and studies in humans, there was a
remaining total of 63 articles. Based on abstracts and titles, 37 studies were removed after applying
study criteria; 5 studies were written in a language other than English (3 in Chinese, 1 in Japanese,
and 1 in German), 5 were eliminated because they did not practice oral distraction in the alveolar
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bone, and 27 studies were removed because horizontal distraction was performed. After full text
reading, 26 studies [8,11–34] complying with the inclusion rules were selected for the review. Twenty
studies were in dogs (with a total of 145 animals and 223 placed devices), 2 in rabbits (72 animals and
72 devices), 2 in sheep (18 animals and 26 devices), 1 in minipigs (3 animals and 3 devices), and 1 in
baboons (3 animals and 3 devices).
Animals 2020, 10, x 4 of 13 
animals and 7  devic s), 2 i  sheep (18 animal  and 26 devices), 1 in mi ipigs (3 animals and 3 
devices), and 1 in baboons (3 animals and 3 devices). 
 
Figure 1. Flow chart of the selected studies. 
Based on this review, 24 articles were rated as high quality, 2 as medium quality, and 0 as low 
quality. Six studies obtained a maximum score of 9 stars (Table 1). 
All animals used were adults and skeletally mature. The average age by species is 18 months in 
dogs and 13 months in sheep. The most commonly used breed was Mongrel in dogs, New Zealand 
in rabbits, Gottingen in minipigs, and Papio Anubis in non-human primates. The average weight 
was 17.3 kg in dogs (ranging from 9 to 40 kg), 4.1 kg in rabbits (ranging from 4.15 to 0.55 kg), and 45 
in sheep. 
The 26 articles selected involved 241 patients with 327 distractors; 158 patients had been treated 
with an extraosseous and 83 with an intraosseous device (Table 2). 
Indication and location for distraction. In 23 studies (217 patients), the jaw was used for 
distraction and in 3 the maxilla (24 patients). The most common location for distraction was the 
posterior region of the left jaw in all species (82 patients), followed by the posterior region of the 
right jaw (59 patients); 220 patients had unilateral and 21 bilateral oral distraction (Supplementary 
Table S3). 
Device details. Thirteen different types of commercial distraction devices and other prototypes 
were found: 
- 8 intraosseous devices: 3i (Standard threaded implant, 3i System, Implant Innovations, West 
Palm Beach, FL, USA), DL-system (Dep. of Oral & Maxillofacial Surgery, Fourth Military 
Medical University, Shaanxi, China), AW (Alveo-Wider; Okada Medical Supply, Tokyo, Japan), 
DK KXSLD (Dikang Biomedical Co., Ltd., Chengdu, China), STATA 4.0 (STATA Corp, College 
Station, TX, USA), OMS (Oral & Maxillofacial Surgery, School of Stomatology, The 4th Military 
Medical Univ, Xi’an, China), ABDUL (Dentium Co Ltd., Seoul, Korea & Osstem Co Ltd., Seoul, 
Korea), and DID (DID-Trade Inc., Klagenfurt, Austria). 
- 5 extraosseous devices: KLS Martin (Tuttlingen, Germany), OPD (U-shaped body, Synthes 
Maxillofacial, Paoli, PA, USA), KLS Martin (Jacksonville, FL, USA), TRACK 1.0 mm-System 
(Gebrüder Martin GmbH & Co. KG, Tuttlingen, Germany), and Impladent SL (Barcelona, 
Spain).  
Figure 1. Flo t f t e selected studies.
Based on this review, 24 articles were rated as high quality, 2 as medium quality, and 0 as low
quality. Six studies obtained a maximum score of 9 stars (Table 1).
All animals used were adults and skeletally mature. The average age by species is 18 months in
dogs and 13 months in sheep. The most commonly used breed was Mongrel in dogs, New Zealand
in rabbits, Gottingen in minipigs, and Papio Anubis in non-human primates. The average weight
was 17.3 kg in dogs (ranging from 9 to 40 kg), 4.1 kg in rabbits (ranging from 4.15 to 0.55 kg), and 45
in sheep.
The 26 articles selected involved 241 patients with 327 distractors; 158 patients had been treated
wit an extraosseous and 83 with an intraosseous device (Table 2).
Indication and location for distraction. In 23 studies (217 pati nts), the jaw was used for distraction
and in 3 the maxilla (24 patients). The most common location for distractio was the posterior region
of the left jaw in all species (82 patients), followed by the posterior region of the right jaw (59 patients);
220 patients had unilateral and 21 bilateral oral distraction (Supplementary Table S3).
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Table 1. Score by studies using NOS Scale.
Author Year Specie Stars Quality
Cano [11] 2006 Dog 9 High
Esposito [12] 2017 Dog 9 High
Li [13] 2014 Dog 9 High
Terbish [14] 2015 Dog 9 High
Zhan [15] 2018 Dog 9 High
Shao [21] 2013 Dog 9 High
Altug [16] 2011 Rabbit 8 High
Faber [17] 2005 Dog 8 High
Oda [19] 2000 Dog 8 High
Oda [18] 1999 Dog 8 High
Rachmiel [20] 2004 Sheep 8 High
Yi [22] 2009 Dog 8 High
Zhao [23] 2009 Dog 8 High
Block [24] 1998 Dog 8 High
Block [25] 1996 Dog 8 High
Block [26] 2000 Dog 8 High
Demetoglu [27] 2017 Dog 8 High
Martínez-González [8] 2005 Minipig 8 High
Martínez-González [8] 2005 Dog 8 High
Perry [28] 2006 Dog 8 High
Takeuchi [29] 2010 Dog 8 High
Xie [30] 2012 Dog 7 High
Boyne [31] 2004 Baboon 7 High
Gaggl [32] 2000 Sheep 7 High
Bayar [33] 2012 Rabbit 6 Medium
Hwang [34] 2004 Dog 5 Medium
Device details. Thirteen different types of commercial distraction devices and other prototypes
were found:
- 8 intraosseous devices: 3i (Standard threaded implant, 3i System, Implant Innovations, West Palm
Beach, FL, USA), DL-system (Dep. of Oral & Maxillofacial Surgery, Fourth Military Medical
University, Shaanxi, China), AW (Alveo-Wider; Okada Medical Supply, Tokyo, Japan), DK KXSLD
(Dikang Biomedical Co., Ltd., Chengdu, China), STATA 4.0 (STATA Corp, College Station, TX,
USA), OMS (Oral & Maxillofacial Surgery, School of Stomatology, The 4th Military Medical Univ,
Xi’an, China), ABDUL (Dentium Co Ltd., Seoul, Korea & Osstem Co Ltd., Seoul, Korea), and DID
(DID-Trade Inc., Klagenfurt, Austria).
- 5 extraosseous devices: KLS Martin (Tuttlingen, Germany), OPD (U-shaped body, Synthes
Maxillofacial, Paoli, PA, USA), KLS Martin (Jacksonville, FL, USA), TRACK 1.0 mm-System
(Gebrüder Martin GmbH & Co. KG, Tuttlingen, Germany), and Impladent SL (Barcelona, Spain).
The most commonly used distractor device was OPD, which was employed in 2 studies and
treated 72 patients [33,34]. The same prototype of Impladent SL (Barcelona) was used in 2 studies to
treat a total of 11 patients [8,11]. The rest of devices were used in just 1 study.
The total number of movable segments were 278. One or more devices may have been placed
per segment.
VAOD protocol. A latency period of 7 days was by most of the studies, with a mean of 6.13, ranging
from 0 [15] to 8 days [12]. In the distraction period, there were multiple sequences in terms of frequency
and rate. This was the period with most discrepancies. However, in none of the studies was performed
the daily augmentation of over 1 mm. Ten days was the distraction period in most of the studies,
with an average of 9.15 (ranging from 5 to 28) days. The mean distraction rate was 0.8 (0.25 to 1 mm)
per day. The distraction frequency varied between 1 and 2 times per day. In one study, the frequency
was 1 time every two days [13]. The consolidation period average was 9.93 weeks (ranging from 0
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to 50 weeks). Zhan et al. [15] did not have a consolidation period (0 weeks). Oda et al. [18] applied
the longest consolidation period (50 weeks). Table 3 shows in detail the characteristics of the latency,
distraction, and consolidation phases of the studies included in the review.
Vertical bone gain. The main gain achieved in these studies was 6.13 mm (ranging from 2.72
to 8.96 mm). The average gain for extraosseous distractors was 6.26 mm and 6.02 in the case of
intraosseous distractors. The study with the highest gain was that of Xie et al. [30], who recorded
a gain of 8.96 mm, using an intraosseous distractor (STATA 4.0) (STATA Corp, College Station, TX,
USA), whereas the lowest gain (2.72 mm) was obtained by Esposito et al. [12], using an intraosseous
prototype. For extraosseous devices, Block et al. [24] obtained the highest bone gain (8.85 mm) using a
prototype, while the lowest (3.25 mm) was obtained by Terbish et al. [14], using a prototype device.
Quantification methods. The quantification methods used whereas follows: histomorphometry
(21 studies), X-rays (17 studies), microtomography (5 studies), immunohistochemistry (1 study),
and fluorescence microscopy (1 study).
Complications and treatment. Complications were found in 12 studies, whereas 11 studies claimed
to have had no complications; 3 of them did not supply information.
Out of 241 patients, 24 (9.95%) exhibited complications; 11 of them (4.56% of the total) were
major and 13 (5.1% of the total) minor complications. By order of frequency, the minor complications
were infection (5 patients, 20.83% out of complications), edema (5, 20.83%), dehiscence (2, 8.32%),
and alveolar arterial hemorrhage (1, 4.16%). Using the same criteria, the major complications were:
device removal due to a moderate infection (6, 25%), support plate deviation (2, 8.32%), intra-surgical
death (1, 4.16%), mandibular fracture (1, 4.16%), and severe diarrhea and death (1, 4.16%).
In 3.31% of the total patients, the distractor was affected due to moderate infection and death of
animals, which had to be removed from the study.
Table 4 shows the complications and treatment classified according to the protocol phase.
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Table 2. Individual parameters of each study (P = prototype).
Author Year DistractorDesign Animal Breed
Patient
Number
Age
(Months) Weight (Kg)
N◦
Distractors
N◦
Segments Extraosseous Intraosseous
Terbish [14] 2015 P Dog Beagle 16 16 to 18 15 to 16 16 16 16 /
Oda [18] 1999 3i Dog Mongrel 5 Adult 15 to 17 10 5 / 10
Takeuchi [29] 2010 TRACK Dog Beagle 11 12 to 24 10 11 11 11 /
Zhao [23] 2009 DL Dog Mongrel 6 18 / 12 6 / 12
Block [24] 1998 P Dog Mongrel 4 Adult / 4 4 4 /
Cano [11] 2006 Impladent SL Dog Beagle 5 24 10 to 15 4 5 4 /
Faber [17] 2005 P Dog Mongrel 5 Adult 11 to 16.4 10 5 10 /
Perry [28] 2005 P Dog American foxhound 5 Adult 25 to 30 5 5 / 5
Demetoglu [27] 2017 P Dog Beagle 10 Adult 35 to 40 20 20 / 20
Oda [19] 2000 P Dog Mongrel 6 Adult 17 to 20 12 6 6 /
Block [25] 1996 P Dog Mongrel 4 Adult / 4 4 4 /
Li [13] 2014 DK KXSLD Dog Mongrel 9 24 20 18 18 / 18
Block [26] 2000 P Dog Mongrel 8 Adult / 8 8 / 8
Xie [30] 2012 STATA 4.0 Dog Mongrel 18 Adult 21 to 26 36 18 / 36
Shao [21] 2013 OMS Dog Mongrel 6 24 / 18 12 / 12
Hwang [34] 2004 ABDUL Dog Beagle 4 Adult / 4 4 / 4
Yi [22] 2009 P Dog Mongrel 4 Adult 9 to 10 8 8 8 /
Esposito [12] 2017 P Dog Beagle 4 19 to 27 12.8 16 12 / 16
Zhan [15] 2018 P Dog Beagle 12 12 to 15 7 to 10 4 12 4 /
Rachmiel [20] 2004 KLS Martin Sheep / 10 12 45 10 10 10 /
Gaggl [32] 2000 DID Sheep / 8 36 / 16 8 / 16
Martínez-González [8] 2005 Impladent SL Dog Beagle 3 Adult / 3 3 3 /
Martínez-González [8] 2005 Impladent SL Minipig Göttingen 3 Adult / 3 3 3 /
Boyne [31] 2004 KLS Martin Monkey Papio anubis baboons 3 Adult / 3 3 3 /
Altug [16] 2011 OPD Rabbit New Zealand 36 Adult 4.15 ± 0.55 36 36 36 /
Bayar [33] 2012 OPD Rabbit New Zealand 36 Adult / 36 36 36 /
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Table 3. Distraction protocol details of each study.
Author Year Distractor Detail Animal Latency Days DistractionDays
Consolidation
Weeks Rate/Frequency Gain (mm)
Terbish [14] 2015 P Dog 7 10 2 to 6 0.4 mm/twice daily 3.25 ± 0.95
Oda [18] 1999 3i Dog 7 6 50 0.9 mm/day 3.98 ± 0.39
Takeuchi [29] 2010 TRACK Dog 7 6 8 0.9 mm/day -
Zhao [23] 2009 DL Dog 7 8 12 1 mm/day 7.25 ± 0.40
Block [24] 1998 P Dog 7 10 10 0.5 mm/twice daily 8.85
Cano [11] 2006 Impladent SL Dog 7 5 4 and 8 1 mm/day 5.49 ± 0.9
Faber [17] 2005 P Dog 7 9 0 to 14 0.65 mm/day 5.45 ± 2.01
Perry [28] 2005 P Dog 7 10 12 0.5 mm/twice daily -
Demetoglu [27] 2017 P Dog 7 10 12 1 mm/day -
Oda [19] 2000 P Dog 7 7 8 or 12 1 mm/day 6.51
Block [25] 1996 P Dog 7 10 10 0.5 mm/twice daily -
Li [13] 2014 DK KXSLD Dog 5 12 4, 8 and 12 1 mm/2 days 5.71
Block [26] 2000 P Dog 7 10 10 0.5 mm/twice daily 8.8 ± 1
Xie [30] 2012 STATA 4.0 Dog 7 - 12 and 24 - 8.96 ± 1.89
Shao [21] 2013 OMS Dog 5 12 4, 8 and 12 1 mm/2 days 5.8 ± 0.2
Hwang [34] 2004 ABDUL Dog - - - - -
Yi [22] 2009 P Dog 7 5 6 0.5 mm/twice daily -
Esposito [12] 2017 P Dog 8 8 10 0.75 mm/day 2.72
Zhan [15] 2018 P Dog 0 28 0 0.5 mm/2 days -
Rachmiel [20] 2004 KLS Martin Sheep 5 24 12 0.5 mm/day -
Gaggl [32] 2000 DID Sheep 7 8 4, 8, 12 and 24 0.5 mm/day -
Martínez-González [8] 2005 Impladent SL Dog 7 5 2 1 mm/day -
Martínez-González [8] 2005 Impladent SL Minipig 7 5 2 1 mm/day -
Boyne [31] 2004 KLS Martin Baboon 7 10 20 1 mm/day -
Altug [16] 2011 OPD Rabbit 1 and 7 10 2, 4 and 8 0.25 mm/twice daily -
Bayar [33] 2012 OPD Rabbit 7 10 2, 4, and 8 0.25 mm/twice daily -
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Table 4. Complications and treatments of the selected studies.
Author Year No. Patients Complications Affected Patients Period Major/Minor Treatment
Terbish [14] 2015 16 Infection 2 (12.5%) Phase 3. Distraction Minor Conservative
Oda [18] 1999 5
Dehiscence 2 (40%) Phase 3. Distraction Minor Conservative
Infection 2 (40%) Phase 4. Consolidation Minor Conservative
Takeuchi [29] 2010 11 No
Zhao [23] 2009 6 Several diarrhea 1 (16.67%) Phase 2. Latency Major Death
Block [24] 1998 4 Alveolar artery cut 1 (25%) Phase 1. Surgery Minor Suture
Cano [11] 2006 5 Moderate Infection 2 (40%) Phase 2. Latency Major Device removal
Faber [17] 2005 5 Moderate edema 5 (100%) Phase 2. Latency Minor Conservative
Perry [28] 2005 5 No
Demetoglu [27] 2017 10
Intra-surgery death 1 (10%) Phase 1. Surgery Major Death
Infection 1 (10%) Phase 4. Consolidation Minor Conservative
Oda [19] 2000 6 Support platedeviation 2 (33.34%) Phase 3. Distraction Major Screw recolocation
Block [25] 1996 4 No
Li [13] 2014 9 No
Block [26] 2000 8 No
Xie [30] 2012 18 No
Shao [21] 2013 6 No
Hwang [34] 2004 4 * * * * *
Yi [22] 2009 4 No
Esposito [12] 2017 4 Mandibular fracture 1 (25%) Phase 4. Consolidation Major Euthanasia
Zhan [15] 2018 12 No
Rachmiel [20] 2004 10 No
Gaggl [32] 2000 8 * * * * *
Martínez-González [8] 2005 3 Moderate Infection 1 (33.34%) Phase 3. Distraction Major Device removal
Martínez-González [8] 2005 3 Moderate Infection 3 (100%) Phase 2. Latency Major Device removal
Boyne [31] 2004 3 * * * * *
Altug [16] 2011 36 No
Bayar [33] 2012 36 * * * * *
* No mention any about complications.
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4. Discussion
This review focused on a total of 26 studies that evaluated VAOD. So far, there is no consensus
about which is the ideal animal for vertical alveolar distraction tests. In this review, the most commonly
used animal, with the least complications, was the dog (20 out of 26 studies; 145 out of 241 animals;
140 out of 327 devices). Among the breeds, Mongrel was the most used (11 out of 20 studies).
Bone regeneration in OD has been related to the age of the patient; faster in young patients,
and slower in older ones. In a study performed in rats aged between 4 and 24 months, statistically
significant differences were observed in the radiodensity of distracted segment of tibiae; 95% of
mineralized bone was observed in 4 month-old rats, whereas in 24 month-old rats, up to 36% of
mineralized bone was observed [35]. All the animals included in this review were skeletally mature
(average of 18 months in dogs and 13 months in sheep), suggesting that the results were not affected
by the patient’s age.
Although the procedure of VAOD has been used for over 25 years, there is still controversy over
the ideal VAOD protocol. However, the clinical phases of the process (osteotomy, latency, distraction,
and consolidation) have remained the same. Most of the studies in this review used a latency phase of
7 days, with a mean of 6.13 (ranging from 0 to 8) days, with similar results. Altug et al. [16] compared
two different latency periods (1 and 7 days) in rabbits, not observing differences in the characteristics
and quantity of the new bone. In human studies, no significant differences were observed. In a set of
3278 dossiers of clinical cases of cranio-facial distraction, Mofid et al. [36] did not find any significant
differences between clinicians that established a latency period and those who did not, in terms of
parameters such as absence of fibrous union (0.4% vs. 0.25%) or premature consolidation (2% vs.
0.76% of cases). However, a latency period of 4–7 days is advisable in alveolar OD with the objective
of avoiding premature exposure of bone to the oral environment [37]. This issue may be even more
important when we use an animal model.
The period between the initial and the final activation of the distractor is called distraction period.
There are multiple options for rate and distraction frequency. Most authors agree on a maximum of
1 mm per day. In this review, the rate oscillated between 0.25 and 1 mm, with a mean of 0.8 mm per
day. There are no previous reviews of studies on animals. In humans, a rate ranging between 0.375
and 1 mm [3] or between 0.44 to 0.98 mm [10] per day was found.
Regarding the frequency of distraction, this delicate phase needs to be performed by specially
trained staff. In this study, the ranges varied mostly from one to two times per day. In one study,
distraction was used once every two days [13]. When distraction is applied more than 2 times a
day it can complicate the procedure [3] and may be the reason for applying a low rate of distraction
in animals.
Osteogenic distraction is a technique with the capacity of producing an increase in the height
of the alveolar bone that may vary between 4 and 15 mm, with a mean of 9.9 mm [38]. The mean
gain obtained by VAOD in this review was 6.13 mm, being greater with extraosseous distraction
devices than with intraosseous ones (6.26 vs. 6.02 mm). A limitation of the present review was that
the vertical gain obtained by VAOD was not directly compared with other surgical techniques for
bone augmentation like xenogenic (5.2 ± 0.79 mm) or alloplastic materials, autogenous bone grafts,
or allografts [39]. Nevertheless, since the height gained with these techniques was lower (e.g. 5.2 ±
0.79 mm for xenogenic), the VAOD technique may be considered as most suitable when the objective is
the vertical bone gain [1,3].
In the consolidation period, an average of 9.93 weeks was observed (ranging between 0 and
50 weeks). Many discrepancies were found in comparison with studies in humans, with a mean of
12.05 [3], 11.22 [10], and 11.83 weeks [40]. To observe the fusion of the basal bone with the distracted
segment, a minimum of 10 weeks of consolidation was needed [3]. Shorter consolidation periods used
in animals may be explained by the faster metabolism compared to humans.
Multiple ways to classify complications were studied. In this review, we used a modification of
the classification carried out by Enislidis et al. [9] and Saulacic et al. [10]. These authors classified the
Animals 2020, 10, 2347 11 of 13
complications into major and minor, and based on when these complications occurred. We found
complications in 12 studies (24 patients, 9.95% of the total). Eleven patients (4.56% of the total) showed
major and minor complications in 13 studies (5.39%). Out of the patients with major complications, 9 had
to be discarded (3.73% of failures). Similar failure rates were observed in human studies, with 3.44% of
failures [3]. Other major complications were solved with the relocation of the distraction device.
The maintenance of an appropriate level of oral hygiene in animals is sometimes a great challenge.
Therefore, surgical sites in the mouth of animals are more likely to get infected, thus increasing the
failure rate. Management of pigs and minipigs may be especially difficult, due to the chewing habits,
affecting the failure rate
According to other studies, the most common minor complication is dehiscence [9,38]. It is also
advisable to reduce the frequency and the rate of distraction if the dehiscence is considerable and
persists [3]. For minor complications, such as inflammations, dehiscence, and infections, conservative
treatment is advised. Minor complications usually have a simple solution, which does not interfere
with the results of the technique.
5. Conclusions
The animal model used in VAOD studies has a marked influence on the results. Within the
limitations of the present study, the animal model mostly used and recommendable in VAOD, which
shows the least complication was the Mongrel dog. Given the difficulties in handling along with the
complications encountered, the use of the pig and minipig as a model for VAOD is not recommended.
The possibility to achieve an adequate level of oral hygiene and to reduce the rate and rhythm of
activation should be further considered when selecting a suitable animal model for VAOD.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2615/10/12/2347/s1,
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